Rare recurrence pattern after complete response to chemotherapy in a patient with rectal cancer: a case report.

Bladder Colorectal cancer Metastasis Skin Small intestine

Journal

Surgical case reports
ISSN: 2198-7793
Titre abrégé: Surg Case Rep
Pays: Germany
ID NLM: 101662125

Informations de publication

Date de publication:
08 May 2024
Historique:
received: 08 03 2024
accepted: 26 04 2024
medline: 8 5 2024
pubmed: 8 5 2024
entrez: 7 5 2024
Statut: epublish

Résumé

Colorectal cancer (CRC) often metastasizes to the liver, lungs, lymph nodes, and peritoneum but rarely to the bladder, small intestine, and skin. We here report the rare metastasis of anal cancer in the left bladder wall, followed by metastases to the small intestine and skin, after abdominoperineal resection and left lateral lymph node dissection with chemotherapy in a patient with clinician Stage IVa disease. A 66-year-old man presented with 1-month history of bloody stool and anal pain and diagnosed with clinical Stage IVa anal cancer with lymph node and liver metastases (cT3, N3 [#263L], M1a [H1]). Systemic chemotherapy led to clinical complete response (CR) for the liver metastasis and clinical near-CR for the primary tumor. Robot-assisted laparoscopic perineal rectal resection and left-sided lymph node dissection were performed. Computed tomography during 18-month postoperative follow-up identified a mass in the left bladder wall, which was biopsied with transurethral resection, was confirmed as recurrent anal cancer by histopathologic evaluation. After two cycles of systemic chemotherapy, partial resection of the small intestine was performed due to bowel obstruction not responding to conservative therapy. The histopathologic evaluation revealed lymphogenous invasion of the muscularis mucosa and subserosa of all sections. Ten months after the first surgery for bowel obstruction and two months before another surgery for obstruction of the small intestine, skin nodules extending from the lower abdomen to the thighs were observed. The histopathologic evaluation of the skin biopsy specimen collected at the time of surgery for small bowel obstructions led to the diagnosis of skin metastasis of anal cancer. Although panitumumab was administered after surgery, the patient died seven months after the diagnosis of skin metastasis. This case illustrates the rare presentation of clinical Stage IVa anal cancer metastasizing to the bladder wall, small intestine, and skin several years after CR to chemotherapy.

Sections du résumé

BACKGROUND BACKGROUND
Colorectal cancer (CRC) often metastasizes to the liver, lungs, lymph nodes, and peritoneum but rarely to the bladder, small intestine, and skin. We here report the rare metastasis of anal cancer in the left bladder wall, followed by metastases to the small intestine and skin, after abdominoperineal resection and left lateral lymph node dissection with chemotherapy in a patient with clinician Stage IVa disease.
CASE PRESENTATION METHODS
A 66-year-old man presented with 1-month history of bloody stool and anal pain and diagnosed with clinical Stage IVa anal cancer with lymph node and liver metastases (cT3, N3 [#263L], M1a [H1]). Systemic chemotherapy led to clinical complete response (CR) for the liver metastasis and clinical near-CR for the primary tumor. Robot-assisted laparoscopic perineal rectal resection and left-sided lymph node dissection were performed. Computed tomography during 18-month postoperative follow-up identified a mass in the left bladder wall, which was biopsied with transurethral resection, was confirmed as recurrent anal cancer by histopathologic evaluation. After two cycles of systemic chemotherapy, partial resection of the small intestine was performed due to bowel obstruction not responding to conservative therapy. The histopathologic evaluation revealed lymphogenous invasion of the muscularis mucosa and subserosa of all sections. Ten months after the first surgery for bowel obstruction and two months before another surgery for obstruction of the small intestine, skin nodules extending from the lower abdomen to the thighs were observed. The histopathologic evaluation of the skin biopsy specimen collected at the time of surgery for small bowel obstructions led to the diagnosis of skin metastasis of anal cancer. Although panitumumab was administered after surgery, the patient died seven months after the diagnosis of skin metastasis.
CONCLUSIONS CONCLUSIONS
This case illustrates the rare presentation of clinical Stage IVa anal cancer metastasizing to the bladder wall, small intestine, and skin several years after CR to chemotherapy.

Identifiants

pubmed: 38714637
doi: 10.1186/s40792-024-01913-x
pii: 10.1186/s40792-024-01913-x
doi:

Types de publication

Journal Article

Langues

eng

Pagination

114

Informations de copyright

© 2024. The Author(s).

Références

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–49.
doi: 10.3322/caac.21660 pubmed: 33538338
Colorectal Cancer Study Group. JSCCR guidelines 2022 for the treatment of colorectal cancer. Tokyo: Kanehara Publishing; 2022.
Wang DY, Ye F, Lin JJ, Xu X. Cutaneous metastasis: a rare phenomenon of colorectal cancer. Ann Surg Treat Res. 2017;93:277–80.
doi: 10.4174/astr.2017.93.5.277 pubmed: 29184882 pmcid: 5694720
Riihimäki M, Hemminki A, Sundquist J, Hemminki K. Patterns of metastasis in colon and rectal cancer. Sci Rep. 2016;6:29765.
doi: 10.1038/srep29765 pubmed: 27416752 pmcid: 4945942
Parente P, Ciardiello D, Reggiani Bonetti L, Famiglietti V, Cazzato G, Caramaschi S, et al. Cutaneous metastasis from colorectal cancer: making light on an unusual and misdiagnosed event. Life (Basel). 2021;11:954.
pubmed: 34575102
Gill SS, Heuman DM, Mihas AA. Small intestinal neoplasms. J Clin Gastroenterol. 2001;33:267–82.
doi: 10.1097/00004836-200110000-00004 pubmed: 11588539
Sugihara K, Ajioka Y, Ishiguro S, Isomoto H, Iwashita A, Iwama T. Japanese classification of colorectal, appendiceal, and anal carcinoma. 3rd ed. Tokyo: Kanehara & Co., Ltd.; 2019.
Bi L, Huang H, Fan X, Li K, Xu K, Jiang C, et al. Extended vs non-extended pelvic lymph node dissection and their influence on recurrence-free survival in patients undergoing radical cystectomy for bladder cancer: a systematic review and meta-analysis of comparative studies. BJU Int. 2014;113:E39-48.
doi: 10.1111/bju.12371 pubmed: 24053715
Kojima Y, Matsumoto F, Mikami Y, Namekata K, Takei M. Metastatic small bowel tumor from descending colon cancer with extensive hematogenous or lymphogenous spread: survey of the Japanese literature. Case Rep Gastroenterol. 2010;4:340–5.
doi: 10.1159/000320649 pubmed: 21060697 pmcid: 2974996
Meshikhes AW, Joudeh AA. Late metastatic colon cancer masquerading as primary jejunal carcinoma. Ann R Coll Surg Engl. 2016;98:e49-51.
doi: 10.1308/rcsann.2016.0091 pubmed: 26890851 pmcid: 5226176
Sato H, Shibasaki S, Okabe A, Tsukamoto T, Morise Z, Uyama I. Hematogenous intestinal metastases from sigmoid colon cancer presenting as iliopsoas abscess and bowel obstruction. Int Cancer Conf J. 2019;8:105–8.
doi: 10.1007/s13691-019-00364-8 pubmed: 31218184 pmcid: 6545184
Faye PM, Cagniet A, Abousarhan F, Jolidon C. Atypical localization of colorectal cancer metastasis one case and literature review. Int J Surg Case Rep. 2020;77:18–21.
doi: 10.1016/j.ijscr.2020.10.073 pubmed: 33137665 pmcid: 7610026
Zhou JC, Wang JJ, Liu T, Tong Q, Fang YJ, Wu ZQ, et al. Primary ascending colon cancer accompanying skip metastases in left shoulder skin and left neck lymph node: a case report. World J Clin Cases. 2022;10:8262–70.
doi: 10.12998/wjcc.v10.i23.8262 pubmed: 36159527 pmcid: 9403686

Auteurs

Masatoshi Nomura (M)

Department of Gastroenterological Surgery, Osaka Rosai Hospital, Nagasone 1179-3, Kita Ward, Sakai, Osaka, 591-8025, Japan. mnomura64@gmail.com.

Mitsuyoshi Tei (M)

Department of Gastroenterological Surgery, Osaka Rosai Hospital, Nagasone 1179-3, Kita Ward, Sakai, Osaka, 591-8025, Japan.

Takayoshi Goto (T)

Department of Pathology, Osaka Rosai Hospital, Sakai, Osaka, 591-8025, Japan.

Masataka Hirano (M)

Department of Gastroenterological Surgery, Osaka Rosai Hospital, Nagasone 1179-3, Kita Ward, Sakai, Osaka, 591-8025, Japan.

Kentaro Nishida (K)

Department of Gastroenterological Surgery, Osaka Rosai Hospital, Nagasone 1179-3, Kita Ward, Sakai, Osaka, 591-8025, Japan.

Soichiro Mori (S)

Department of Gastroenterological Surgery, Osaka Rosai Hospital, Nagasone 1179-3, Kita Ward, Sakai, Osaka, 591-8025, Japan.

Yukihiro Yoshikawa (Y)

Department of Gastroenterological Surgery, Osaka Rosai Hospital, Nagasone 1179-3, Kita Ward, Sakai, Osaka, 591-8025, Japan.

Koki Tamai (K)

Department of Gastroenterological Surgery, Osaka Rosai Hospital, Nagasone 1179-3, Kita Ward, Sakai, Osaka, 591-8025, Japan.

Takuya Hamakawa (T)

Department of Gastroenterological Surgery, Osaka Rosai Hospital, Nagasone 1179-3, Kita Ward, Sakai, Osaka, 591-8025, Japan.

Daisuke Takiuchi (D)

Department of Gastroenterological Surgery, Osaka Rosai Hospital, Nagasone 1179-3, Kita Ward, Sakai, Osaka, 591-8025, Japan.

Masanori Tsujie (M)

Department of Gastroenterological Surgery, Osaka Rosai Hospital, Nagasone 1179-3, Kita Ward, Sakai, Osaka, 591-8025, Japan.

Yusuke Akamaru (Y)

Department of Gastroenterological Surgery, Osaka Rosai Hospital, Nagasone 1179-3, Kita Ward, Sakai, Osaka, 591-8025, Japan.

Classifications MeSH